As researchers continue to study the impacts of biofilms on wounds, individuals living with chronic wounds often experience a negative impact on their overall physical and mental health, especially for those whose wounds continue for months or even years. Chronic wound patients commonly report concerns

Kane Biotech experienced significant achievements in October 2022, for both their coactiv+™ and their DispersinB® technologies. For over 20 years, Kane has been developing new technologies and innovations, leading to 80 patents and patents pending in biotechnology focusing primarily on biofilm. Kane Biotech Announces 510(k)

Antimicrobial resistance (AR) occurs when bacteria are exposed to levels of antibiotics that fail to kill the bacteria. For example, when an antibiotic that was able to treat an infection previously is no longer able to effectively kill bacteria, and results in an ongoing or

The National Institute of Health reports that 80% of all known human infections are associated with biofilms. Biofilms are a serious and urgent clinical and financial burden to health care systems and patients, costing industry, cities, and hospitals over $500 billion each year. What are

If you have never heard of biofilms before, you are not alone. Biofilms may be an uncommon word, but they impact our lives and health in many ways – including keeping us sick. A simple way to describe a biofilm is it being a glue-like